Announcements Trials
Browse Landscape

Status

Completed 2Withdrawn 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 3Plasma cell 2Genitourinary 2Sarcoma 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Multiple Myeloma 2Patient Compliance 1Osteolysis 1Bone Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 60palbociclib 37Trastuzumab 31Letrozole 26Immunohistochemistry 26Drug Therapy 24Anastrozole 24Radiotherapy 21Gene Expression Profiling 20Amplified Fragment Length Polymorphism Analysis 20Mastectomy, Segmental 19Biopsy 19Tamoxifen 18exemestane 17Interviews as Topic 17ribociclib 16Mastectomy 16Fulvestrant 16Paclitaxel 15Magnetic Resonance Spectroscopy 15Psychiatric Rehabilitation 14High-Energy Shock Waves 14Polymerase Chain Reaction 13Observation 13Microarray Analysis 13Capecitabine 13trastuzumab deruxtecan 12Neoadjuvant Therapy 12Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms × Clodronic Acid × Clear all
NCT00873808 2013-04-10

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

SWOG Cancer Research Network

Withdrawn
Breast

Breast Neoplasms

NCT01198457 2012-09-07

BONA

Bayer

Completed
147 enrolled
BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Osteolysis, Patient Compliance, Prostatic Neoplasms

NCT00909142 2012-04-06

BICAM

Bayer

Completed
149 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡